Insider Purchases: Inside the Buy

Tag: CashBurn

Digital illustration of biotech company MaxCyte (MXCT): glowing cell zapped by electricity ⚡ with executives buying shares 🛒💉, symbolizing insider buys vs. cash burn.

August 16, 2025

MaxCyte (MXCT) — Insiders Load Up While Cash Burns

MaxCyte insiders are shopping biotech shares like it’s Black Friday 🛒💉. With revenue slipping, cash burning, but institutions holding, is MXCT a comeback spark ⚡ or a treadmill burn-out 🔥?

Read entire article

Tags: BiotechStocks, CashBurn, CellTherapy, CEO Buys, CEO Conviction, CEO insider buying, CEO Stock Purchase, CEOBuyIn, CEOConfidence, CFO Bought Shares, CFO Insider Buying, CFOBuyIn, DIrector Buying, Director Insider Buying, Funanc1al, Funanc1al Stocks to Watch, Funanc1alBiotech, Funanc1alEdge, Funanc1alHealth, Funanc1alInsiders, Funanc1alInsiderSeries, Funanc1alInsights, Funanc1alInvesting, Funanc1alStocks, HighRiskHighReward, InsiderBuying, InstitutionalOwnership, MaxCyte, MXCT, SpeculativePlays

Quanterix stock infographic with insider buying highlights, biotech platform icons, and cash flow risk symbols

June 12, 2025

Quanterix Insiders Are Buying. Should You?

Quanterix insiders are buying, and institutions are still in. But revenue is sliding, and losses are deep. A potential comeback or another biotech burn? 🔬💸

Read entire article

Tags: BiotechInvesting, CashBurn, Funanc1al, Funanc1al Edge, Funanc1al for Investors, Funanc1al Insider Series, Funanc1al Investing, Funanc1alEdge, Funanc1alFun, Funanc1alInvesting, Funanc1alStocks, InsiderBuying, LifeSciences, MergersAndAcquisitions, QTRXStock, Quanterix, RiskyPlays

Your cart

Insider Purchases: Inside the Buy

Tag: CashBurn

August 16, 2025

MaxCyte (MXCT) — Insiders Load Up While Cash Burns

June 12, 2025

Quanterix Insiders Are Buying. Should You?

Quick links

Contact us

About us

Follow us